7Baggers
Quarterly
Annual
    Unit: USD2022-04-02 2022-01-01 2021-10-02 2021-07-03 2021-04-03 2021-01-02 2020-10-03 2020-07-04 2020-04-04 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31 2017-12-30 2017-09-30 2017-07-01 2017-04-01 2016-12-31 2016-10-01 2016-07-02 2016-04-02 2016-01-02 2015-10-03 2015-07-04 2015-04-04 2014-12-27 2014-09-27 2014-06-28 2014-03-29 2013-12-28 2013-09-28 2013-06-29 2013-03-30 2012-12-29 2012-09-29 2012-06-30 2012-03-31 2011-12-31 2011-10-01 2011-07-02 2011-01-01 2010-07-03 2010-04-03 2010-01-02 2009-07-04 2009-04-04 2008-12-27 2008-06-28 2008-03-29 2007-12-29 2007-06-30 2006-12-30 2006-07-01 2006-04-01 2005-12-31 2005-09-30 2005-07-02 2005-04-02 2005-01-01 2004-07-03 2004-04-03 2003-12-27 2003-09-30 2003-06-28 2003-03-29 2002-12-28 2001-12-29 
      
                                                                           
      assets
                                                                           
      current assets:
                                                                           
      cash and cash equivalents
    402,020,000 392,552,000 456,534,000 394,098,000 353,049,000 508,214,000 440,258,000 378,992,000 369,251,000 349,592,000 305,833,000 316,458,000 337,321,000 314,997,000 310,495,000 232,458,000 308,987,000 385,735,000 443,066,000 472,307,000 432,980,000 360,217,000 354,347,000 139,407,000 157,176,000 142,343,000 130,607,000 103,138,000 115,081,000 129,420,000 91,217,000 149,568,000 140,251,000 138,375,000 110,444,000 81,311,000 93,604,000 87,996,000 67,761,000 82,580,000 86,064,000 167,662,000 167,061,000 199,681,000 227,515,000 210,351,000 192,166,000 199,760,000 182,331,000 182,951,000 185,235,000 194,131,000 169,784,000 320,795,000 338,899,000 434,826 421,005,000 353,294,000 108,260,000 97,507,000 97,355,000 99,002,000 105,249,000 89,468,000 83,070,000 88,043,000 76,541,000 84,629,000 92,665,000 112,002,000 82,168,000 
      restricted cash
    1,457,000 1,492,000 1,527,000 1,559,000 1,534,000 801,000 765,000 736,000 704,000 728,000 792,000 825,000 814,000 827,000 858,000 1,082,000 1,144,000 1,100,000 1,097,000 1,060,000 1,284,000 2,232,000                       625,000 625,000      2,755,000 2,758,000 2,514,000                  
      accounts receivable
    262,956,000 243,378,000 249,389,000 256,197,000 248,856,000 226,199,000 220,289,000 197,757,000 202,699,000 235,933,000 267,553,000 269,057,000 313,351,000 330,892,000 355,208,000 337,560,000 312,938,000 309,132,000 305,668,000 277,853,000 252,542,000 241,112,000 165,715,000 150,184,000 150,409,000 144,595,000 142,260,000 144,688,000 124,227,000 130,461,000 137,324,000 130,833,000 137,470,000 115,680,000 136,759,000 146,184,000 134,479,000 126,010,000 144,345,000 141,332,000 126,588,000 130,581,000 141,037,000 143,400,000 107,938,000 98,355,000 84,598,000 76,136,000 75,120,000 81,302,000 95,196,000 110,371,000 112,694,000 96,971,000 100,432,000 95,034 102,657,000 99,005,000 84,332,000 87,684,000 81,529,000 90,301,000 86,694,000 88,409,000 91,775,000  73,118,000 74,286,000 83,831,000 80,898,000 74,230,000 
      inventories
    417,275,000 393,629,000 392,241,000 400,547,000 393,672,000 416,381,000 426,756,000 448,972,000 457,358,000 449,571,000 442,530,000 469,486,000 483,741,000 493,156,000 486,741,000 494,967,000 492,686,000 432,809,000 414,807,000 402,849,000 388,242,000 386,013,000 212,898,000 200,171,000 179,067,000 158,006,000 156,614,000 157,778,000 153,659,000 161,993,000 170,483,000 179,767,000 176,462,000 170,958,000 168,067,000 169,003,000 166,865,000 169,002,000 160,113,000 160,095,000 157,057,000 148,047,000 152,385,000 149,465,000 121,210,000 99,409,000 99,144,000 98,924,000 109,039,000 114,239,000 117,973,000 123,444,000 116,567,000 112,889,000 115,079,000 99,792 106,139,000 95,633,000 98,495,000 102,730,000 113,593,000 108,907,000 109,688,000 107,045,000 106,353,000 103,582,000 100,147,000 106,153,000 94,960,000 94,199,000 107,102,000 
      prepaid expenses and other assets
    91,884,000 100,389,000 79,594,000 87,744,000 83,215,000 91,814,000 88,250,000 90,237,000 89,045,000 86,997,000 77,993,000 87,372,000 79,465,000 84,141,000 85,080,000 88,490,000 85,446,000 77,003,000 70,268,000 74,827,000 73,802,000 66,981,000 37,073,000 36,349,000 34,602,000 32,733,000 28,294,000 47,316,000 38,538,000 34,021,000 27,839,000 67,644,000 52,556,000 51,529,000 52,577,000 68,653,000 58,999,000 55,611,000 61,730,000 71,873,000 59,174,000 52,314,000 44,964,000 63,240,000 45,416,000 49,634,000 52,708,000 51,827,000 54,048,000 48,314,000 45,855,000 59,818,000 57,804,000 47,540,000 41,563,000 25,338 28,578,000 20,100,000 13,483,000 17,034,000 22,063,000 19,541,000 16,313,000 25,602,000 23,702,000 26,052,000 45,693,000 62,395,000 36,832,000 46,024,000 29,851,000 
      total current assets
    1,175,592,000 1,131,440,000 1,179,285,000 1,155,274,000 1,095,454,000 1,278,770,000 1,211,664,000 1,158,592,000 1,119,173,000 1,122,821,000 1,094,821,000 1,145,313,000 1,226,172,000 1,229,032,000 1,238,502,000 1,154,557,000 1,247,407,000 1,252,067,000 1,311,664,000 1,261,572,000 1,214,938,000 1,122,164,000 815,639,000 760,316,000 725,136,000 671,508,000 680,801,000 710,939,000 684,690,000 673,191,000 681,055,000 704,837,000 672,236,000 633,376,000 629,226,000 608,088,000 586,099,000 551,483,000 614,485,000 602,791,000 579,968,000 557,290,000 580,646,000 644,770,000 593,221,000 522,312,000 520,994,000 486,461,000 484,278,000 475,054,000 489,669,000 531,967,000 514,833,000 687,832,000 826,070,000 775,587 744,811,000 699,180,000 488,007,000 491,721,000 485,322,000 483,068,000 460,272,000 431,582,000 411,645,000 384,711,000 398,982,000 456,817,000 527,124,000 526,425,000 568,385,000 
      property and equipment
    305,916,000 306,872,000 302,613,000 295,481,000 264,383,000 260,207,000 245,678,000 251,453,000 242,858,000 327,673,000 323,434,000 323,974,000 318,989,000 320,933,000 311,793,000 303,214,000 307,330,000 291,308,000 278,850,000 268,622,000 256,024,000 251,090,000 127,443,000 111,738,000 108,575,000 99,732,000 102,445,000 98,996,000 100,903,000 103,978,000 107,424,000 112,530,000 114,146,000 114,405,000 114,333,000 113,952,000 114,368,000 116,574,000 115,096,000 114,898,000 114,439,000 106,028,000 104,504,000 103,249,000 88,343,000 91,488,000 94,972,000 100,062,000 99,418,000 100,094,000 102,465,000 105,873,000 107,475,000 102,796,000 127,603,000 148,912 150,416,000 151,339,000 153,095,000 155,316,000 156,627,000 162,455,000 168,107,000 167,708,000 167,443,000 171,110,000 146,399,000 290,087,000 278,163,000 267,967,000 261,314,000 
      goodwill
    102,746,000 103,785,000 105,261,000 106,654,000 101,953,000 104,742,000 101,317,000 98,647,000 95,711,000 433,643,000 427,101,000 439,139,000 435,997,000 442,236,000 442,940,000 444,066,000 460,921,000 418,080,000 417,694,000 410,417,000 360,576,000 351,311,000 101,458,000 101,308,000 102,876,000 100,175,000 101,817,000 100,096,000 99,388,000 106,602,000 109,513,000 114,779,000 115,354,000 114,638,000 113,408,000 110,465,000 109,242,000 111,624,000 77,689,000 73,751,000 75,806,000 74,756,000 75,954,000 79,824,000 69,187,000 67,518,000 66,434,000 68,916,000 65,614,000 63,513,000 65,166,000 87,636,000 87,761,000 83,853,000 82,090,000 73,216 72,096,000 69,895,000 68,211,000 68,097,000 67,520,000 58,612,000 55,279,000 52,691,000 52,473,000 52,376,000 50,952,000 54,438,000 34,720,000   
      intangible assets
    12,133,000 13,146,000 14,740,000 17,496,000 16,876,000 19,934,000 21,765,000 24,005,000 26,218,000 73,831,000 84,813,000 101,614,000 119,258,000 135,941,000 142,293,000 157,364,000 180,642,000 174,531,000 190,027,000 202,690,000 206,506,000 233,634,000 13,874,000 16,092,000 18,510,000 20,070,000 22,776,000 22,163,000 23,896,000 28,481,000 31,666,000 36,041,000 38,698,000 40,832,000 42,971,000 44,108,000 46,021,000 50,127,000 9,473,000 13,076,000 14,746,000 16,405,000 17,980,000 20,178,000 17,726,000 21,660,000 20,740,000 23,064,000 21,164,000 22,652,000 24,989,000 30,589,000 32,780,000 33,585,000 36,924,000 37,522 38,694,000 39,423,000 41,287,000 42,186,000 44,366,000 33,693,000 34,963,000 37,500,000 38,689,000 40,343,000 40,327,000 38,220,000    
      non-current restricted cash
    6,998,000 16,225,000 4,460,000 14,587,000 4,508,000 4,661,000 4,497,000 4,486,000 4,341,000 12,258,000 12,036,000 12,486,000 12,338,000 12,514,000 12,692,000 12,738,000 13,432,000 12,957,000 12,924,000 12,524,000 11,786,000 11,543,000                                                  
      other assets
    267,010,000 276,932,000 282,571,000 272,695,000 272,079,000 221,322,000 242,575,000 232,942,000 237,076,000 233,832,000 140,964,000 114,132,000 109,514,000 112,956,000 111,749,000 115,629,000 126,853,000 127,716,000 126,641,000 122,604,000 125,510,000 119,829,000 102,734,000 92,856,000 93,446,000 93,871,000 61,108,000 64,898,000 66,116,000 65,755,000 69,717,000 68,986,000 68,280,000 68,769,000 66,540,000 68,141,000 67,633,000 67,296,000 64,029,000 65,846,000 63,062,000 63,650,000 64,182,000 72,372,000 71,480,000 82,369,000 85,689,000 92,202,000 88,673,000 79,885,000 78,628,000 80,048,000 68,954,000 76,139,000 67,397,000 65,604 55,655,000 55,433,000 48,690,000 39,750,000 32,678,000 43,669,000 36,441,000 31,036,000 29,963,000 32,127,000 34,045,000 22,758,000 48,521,000 77,458,000 88,689,000 
      total assets
    1,870,395,000 1,848,400,000 1,888,930,000 1,862,187,000 1,755,253,000 1,889,636,000 1,827,496,000 1,770,125,000 1,725,377,000 2,204,058,000 2,083,169,000 2,136,658,000 2,222,268,000 2,253,612,000 2,259,969,000 2,187,568,000 2,336,585,000 2,276,659,000 2,337,800,000 2,278,429,000 2,175,340,000 2,089,571,000 1,161,148,000 1,082,310,000 1,048,543,000 985,356,000 968,947,000 997,092,000 974,993,000 978,007,000 999,375,000 1,037,173,000 1,008,714,000 972,020,000 966,478,000 944,754,000 923,363,000 897,104,000 880,772,000 870,362,000 848,021,000 818,129,000 843,266,000 920,393,000 839,957,000 785,347,000 788,829,000 770,705,000 759,147,000 741,198,000 760,917,000 836,113,000 811,803,000 984,205,000 1,163,112,000 1,104,620    798,290,000    744,273,000        
      liabilities and stockholders' equity
                                                                           
      current liabilities:
                                                                           
      short-term borrowings and current-portion of long-term obligations
    9,571,000 9,005,000 18,395,000 17,730,000 16,875,000 17,136,000 16,817,000 16,554,000 16,275,000 16,809,000  45,283,000 46,979,000 46,670,000  7,076,000 7,422,000 6,928,000  5,485,000 5,161,000 7,183,000                                                  
      accounts payable
    106,071,000 100,424,000 104,539,000 108,831,000 93,028,000 62,412,000 60,225,000 68,484,000 62,029,000 55,851,000 51,531,000 62,954,000 68,155,000 74,738,000 70,292,000 82,602,000 93,309,000 81,397,000 75,860,000 72,755,000 73,512,000 66,439,000 45,182,000 44,182,000 43,458,000 28,858,000 33,379,000 32,196,000 31,949,000 27,040,000 32,784,000 32,691,000 33,708,000 30,689,000 36,565,000 40,869,000 39,443,000 29,396,000 29,088,000 38,287,000 40,831,000 35,379,000 39,841,000 45,287,000 40,869,000 31,844,000 29,382,000 24,359,000 18,226,000 20,316,000 21,634,000 29,377,000 33,622,000 26,585,000 33,082,000 27,941 31,070,000 24,365,000 21,310,000 18,451,000 19,457,000 17,226,000 20,220,000 20,622,000 21,311,000 16,778,000 17,632,000 15,740,000 15,817,000 13,919,000 14,741,000 
      income taxes payable
    35,207,000 27,051,000 20,991,000 12,784,000 9,614,000 6,561,000 6,861,000 3,922,000 6,925,000 8,365,000 6,185,000 11,219,000 85,811,000 94,302,000 114,145,000 104,193,000 105,395,000 114,036,000 103,206,000 71,427,000 60,609,000 41,191,000 19,870,000 10,136,000 11,545,000 10,557,000 4,279,000 923,000 1,036,000 1,262,000 2,029,000 13,900,000 11,977,000 10,364,000 24,695,000 18,431,000 28,430,000 27,621,000 33,944,000 21,283,000 13,305,000 15,258,000 23,929,000 17,901,000 11,525,000 1,631,000 2,159,000 1,617,000 1,665,000 1,956,000 1,942,000 8,749,000 6,134,000 3,071,000 25,395,000 15,531 14,837,000 13,250,000 11,112,000 16,597,000 10,199,000 7,997,000 7,123,000 6,570,000 1,709,000 1,270,000 1,361,000 1,775,000 4,228,000 541,000 2,504,000 
      other current liabilities
    203,114,000 208,896,000 238,290,000 231,922,000 223,475,000 210,554,000 184,155,000 174,557,000 176,065,000 175,398,000 167,735,000 169,058,000 163,953,000 161,401,000 183,329,000 158,285,000 195,842,000 190,840,000 235,001,000 229,642,000 231,004,000 198,281,000 116,442,000 92,061,000 89,808,000 79,219,000 84,941,000 96,664,000 99,159,000 87,856,000 82,506,000 105,330,000 99,841,000 90,248,000 84,566,000 103,682,000 103,540,000 101,539,000 90,739,000 108,481,000 99,419,000 94,573,000 98,620,000 112,658,000 88,124,000 98,550,000 84,972,000 71,911,000 80,579,000 74,249,000 70,676,000 103,035,000 91,337,000 85,654,000 94,869,000 75,956 67,301,000 57,570,000 54,853,000 63,803,000 65,647,000 66,589,000 58,948,000 65,721,000 64,576,000 60,129,000 67,980,000 62,310,000 58,472,000 58,017,000 53,760,000 
      total current liabilities
    353,963,000 345,376,000 382,215,000 371,267,000 342,992,000 296,663,000 268,058,000 263,517,000 261,294,000 256,423,000 240,314,000 288,514,000 364,898,000 377,111,000 372,838,000 352,156,000 401,968,000 393,201,000 419,145,000 379,309,000 370,286,000 313,094,000 201,494,000 166,379,000 149,811,000 123,634,000 122,599,000 129,783,000 132,144,000 116,158,000 117,319,000 152,757,000 145,526,000 131,301,000 145,828,000 162,988,000 171,424,000 158,571,000 153,788,000 168,068,000 153,571,000 145,225,000 162,405,000 175,860,000 140,534,000 132,044,000 116,533,000 97,908,000 100,478,000 96,529,000 94,260,000 141,536,000 131,102,000 115,319,000 353,144,000 319,198 113,208,000 107,922,000 100,010,000 111,587,000 108,283,000 105,172,000 99,700,000 106,952,000 101,947,000 92,339,000 101,113,000 119,531,000 86,167,000 94,158,000 104,527,000 
      long-term obligations
    401,540,000 413,799,000 425,800,000 437,269,000 409,622,000 428,823,000 411,140,000 397,264,000 381,718,000 396,153,000 392,238,000 409,836,000 405,837,000 413,505,000 420,711,000 422,285,000 449,653,000 503,005,000 589,001,000 652,700,000 660,105,000 677,323,000                 2,000 6,000 11,000 15,000 19,000 23,000 30,000 37,000 39,000 44,000 8,000 9,000 12,000 17,000 19,000 20,000 1,151,000 1,318 1,451,000 1,376,000   614,000 13,961,000 14,149,000 14,505,000 27,643,000 27,667,000 27,911,000 4,205,000 43,308,000 43,664,000 57,694,000 
      other long-term liabilities
    180,698,000 191,241,000 212,730,000 214,195,000 207,686,000 212,272,000 221,074,000 215,838,000 208,935,000 245,507,000 165,881,000 137,097,000 138,751,000 145,513,000 151,956,000 181,976,000 195,283,000 185,072,000 166,390,000 178,378,000 168,686,000 172,173,000 48,826,000 44,985,000 49,183,000 51,483,000 49,930,000 53,345,000 52,364,000 54,223,000 62,407,000 65,900,000 64,702,000 65,211,000 62,132,000 62,759,000 64,663,000 67,269,000 55,326,000 53,936,000 57,594,000 63,565,000 62,841,000 82,070,000 80,417,000 82,288,000 88,025,000 92,054,000 88,223,000 83,325,000 87,885,000 95,701,000 90,098,000 88,882,000 46,753,000 41,791 61,686,000 60,206,000 58,680,000 50,437,000 51,309,000 52,613,000 50,579,000 39,728,000 36,364,000 32,088,000 29,008,000 47,990,000 65,047,000 60,741,000 55,054,000 
      commitments and contingencies
                                                                           
      stockholders' equity:
                                                                           
      common stock
                                                                       296,000   284,000 
      outstanding— 24,779 shares and 24,538 shares, respectively
    246,000                                                                       
      additional paid-in capital
    131,452,000 123,964,000 123,135,000 113,394,000 97,490,000 89,064,000 80,275,000 66,141,000 44,621,000 34,464,000 34,320,000 24,475,000 34,736,000 51,851,000 78,700,000 70,051,000 155,763,000 147,764,000 171,403,000 162,525,000 151,356,000 145,494,000 151,298,000 145,350,000 136,171,000 130,537,000 128,607,000 174,055,000 166,085,000 168,806,000 184,042,000 179,172,000 171,209,000 166,399,000 162,253,000 156,824,000 149,323,000 137,079,000 131,708,000 128,776,000 122,693,000 114,829,000 130,250,000 183,245,000 205,899,000 196,450,000 205,207,000 193,096,000 187,197,000 184,940,000 182,801,000 161,607,000 159,422,000 382,873,000 379,594,000 374,337 334,770,000 318,126,000 324,214,000 328,580,000 326,018,000 316,516,000 312,067,000 306,997,000 304,338,000 301,771,000 299,378,000 296,340,000 287,984,000 287,343,000 275,298,000 
      accumulated other comprehensive loss
    -27,069,000 -22,115,000 -20,818,000 -18,748,000 -17,084,000 -9,948,000 -25,667,000 -37,562,000 -44,825,000 -21,036,000           -12,178,000 -13,753,000 -5,300,000 -8,449,000 -2,016,000 -17,911,000                                              
      retained earnings
    829,565,000 795,889,000 765,624,000 744,566,000 714,304,000 872,519,000 872,375,000 864,686,000 873,394,000 1,292,307,000 1,286,514,000 1,285,890,000 1,288,989,000 1,268,239,000 1,232,689,000 1,159,504,000 1,092,534,000 1,027,232,000 971,710,000 897,958,000 836,841,000 794,996,000 764,588,000 733,803,000 715,153,000 697,372,000 677,086,000 649,784,000 636,520,000 618,107,000 600,677,000 581,580,000 568,581,000 553,274,000 541,571,000 521,056,000 504,371,000 489,369,000 499,256,000 486,708,000 469,500,000 453,345,000 436,294,000 404,914,000 362,169,000 333,203,000 318,799,000 310,319,000 310,635,000 317,650,000 326,780,000 337,312,000 328,910,000 322,785,000 320,811,000 314,292 307,957,000 297,106,000 288,933,000 279,617,000 274,366,000 264,721,000 249,676,000 234,517,000 229,363,000 226,260,000 226,566,000 251,615,000 253,901,000 251,974,000 344,155,000 
      total stockholders' equity
    934,194,000 897,984,000 868,185,000 839,456,000   927,224,000    1,284,736,000    1,314,464,000    1,163,264,000    910,828,000    796,418,000    819,649,000    758,518,000    671,656,000    618,001,000                             
      total liabilities and stockholders' equity
    1,870,395,000 1,848,400,000 1,888,930,000 1,862,187,000   1,827,496,000    2,083,169,000    2,259,969,000    2,337,800,000    1,161,148,000    968,947,000    999,375,000    966,478,000    880,772,000    843,266,000                             
      outstanding— 24,764 shares and 24,538 shares, respectively
     246,000                                                                      
      short-term investments
       15,129,000 15,128,000 35,361,000 35,346,000 41,898,000 116,000  120,000 2,115,000 11,480,000 5,019,000 120,000  37,127,000 37,711,000 32,510,000 120,000 125,000 125,000 45,606,000 234,205,000 203,882,000 193,831,000 194,908,000 233,628,000 229,353,000 193,531,000 227,058,000 153,692,000 143,217,000 135,302,000 139,666,000 120,371,000 110,386,000 91,781,000 157,168,000 127,024,000 129,111,000 35,421,000 53,142,000 67,758,000 69,059,000 43,656,000 72,943,000 40,866,000 39,557,000 23,849,000 14,644,000 3,586,000 14,842,000 67,569,000 179,486,000 85,862 42,427,000 75,842,000 132,040,000 133,407,000 112,240,000 113,493,000 89,688,000 64,520,000 58,508,000 48,116,000 58,407,000 85,146,000 151,985,000 127,930,000 243,089,000 
      outstanding—24,538 shares and 24,257 shares, respectively
      244,000                                                                     
      outstanding— 24,535 shares and 24,257 shares, respectively
       244,000                                                                    
      liabilities and stockholders’ equity
                                                                           
      outstanding— 24,464 shares and 24,257 shares, respectively
        243,000                                                                   
      total stockholders’ equity
        794,953,000 951,878,000  893,506,000 873,430,000 1,305,975,000  1,301,211,000 1,312,782,000 1,317,483,000  1,231,151,000 1,289,681,000 1,195,381,000  1,068,042,000 976,263,000 926,981,000  870,946,000 849,549,000 810,239,000  813,964,000 790,485,000 807,626,000  818,516,000 798,486,000 775,508,000  719,007,000 687,276,000 671,264,000  648,352,000 636,845,000 609,324,000  662,440,000 618,976,000 570,978,000 584,232,000 580,699,000 570,438,000 561,335,000 578,760,000 598,859,000 590,584,000 779,984,000 762,064,000 742,313 688,336,000 648,624,000 641,799,000 636,266,000 627,531,000 626,296,000 613,683,000 576,073,000 566,298,000 561,240,000 543,858,000 566,710,000 550,920,000 544,750,000 596,266,000 
      total liabilities and stockholders’ equity
        1,755,253,000 1,889,636,000  1,770,125,000 1,725,377,000 2,204,058,000  2,136,658,000 2,222,268,000 2,253,612,000  2,187,568,000 2,336,585,000 2,276,659,000  2,278,429,000 2,175,340,000 2,089,571,000  1,082,310,000 1,048,543,000 985,356,000  997,092,000 974,993,000 978,007,000  1,037,173,000 1,008,714,000 972,020,000  944,754,000 923,363,000 897,104,000  870,362,000 848,021,000 818,129,000  920,393,000 839,957,000 785,347,000 788,829,000 770,705,000 759,147,000 741,198,000 760,917,000 836,113,000 811,803,000 984,205,000 1,163,112,000 1,104,620    798,290,000    744,273,000        
      outstanding— 24,447 shares and 24,257 shares, respectively
         243,000                                                                  
      outstanding—24,257 shares and 23,982 shares, respectively
          241,000                                                                 
      outstanding— 24,256 shares and 23,982 shares, respectively
           241,000                                                                
      outstanding— 24,192 shares and 23,982 shares, respectively
            240,000                                                               
      outstanding— 24,153 shares and 23,982 shares, respectively
             240,000                                                              
      short-term borrowings and current portion of long-term obligations
              14,863,000        5,078,000                                                     
      outstanding—23,982 shares and 24,299 shares, respectively
              238,000 238,000                                                            
      accumulated other comprehensive income
              -36,336,000 -9,392,000 -11,183,000 -2,849,000 2,833,000 1,354,000 41,137,000 20,138,000 19,906,000 7,314,000       -9,513,000 -10,122,000 -12,366,000 20,465,000 34,682,000 57,516,000 58,448,000 55,587,000 54,450,000 40,884,000 33,340,000 44,576,000 40,455,000 32,632,000 44,416,000 40,916,000 51,221,000 74,032,000 50,657,000 41,077,000 59,976,000 77,038,000 72,362,000 58,502,000 68,937,000 99,705,000 102,018,000 74,013,000 61,346,000 53,695 45,623,000 33,411,000 28,668,000 30,846,000 30,178,000 45,442,000 52,359,000 35,016,000 33,090,000 33,701,000 18,409,000 19,252,000 9,885,000 7,001,000  
      outstanding—24,137 shares and 24,299 shares, respectively
                240,000                                                           
      outstanding—24,327 shares and 24,299 shares, respectively
                 242,000                                                          
      assets held for sale
                    9,079,000 8,577,000 44,248,000                                    21,242,000                 
      current portion of long-term obligations
                  5,072,000                    2,000 6,000 11,000 15,000 17,000 17,000 16,000 15,000 15,000 14,000 16,000 19,000 20,000 21,000 8,000 8,000 8,000 9,000 9,000 9,000 8,000  12,737,000 12,735,000 12,736,000 12,980,000 13,360,000 13,409,000 14,039,000 14,351,000 14,162,000 14,140,000 39,706,000 7,429,000 7,781,000 9,986,000 
      outstanding—24,299 shares and 24,631 shares, respectively
                  242,000 242,000                                                        
      stockholders’ equity:
                                                                           
      outstanding—24,834 shares and 24,631 shares, respectively
                    247,000                                                       
      outstanding—24,822 shares and 24,631 shares, respectively
                     247,000                                                      
      outstanding—24,631 shares and 24,324 shares, respectively
                      245,000 245,000                                                    
      assets held-for-sale
                       32,556,000 65,963,000 65,484,000                                                  
      outstanding—24,578 shares and 24,324 shares, respectively
                        244,000                                                   
      outstanding—24,553 shares and 24,324 shares, respectively
                         244,000                                                  
      short term borrowings
                          20,000,000                                                 
      authorized—500,000 shares;
                                                                           
      outstanding—24,324 shares in 2016 and 23,970 shares in 2015
                          242,000                                                 
      short-term borrowings
                           20,000,000 5,000,000 5,000,000                          366,000                710,000 221,000 13,900,000 23,536,000 
      outstanding—24,295 shares and 23,970 shares, respectively
                           242,000                                                
      authorized—500,000 shares
                                                                           
      outstanding—24,218 shares and 23,970 shares, respectively
                            241,000                                               
      outstanding—24,190 shares and 23,970 shares, respectively
                             241,000                                              
      deferred tax assets
                              28,118,000 24,391,000 23,832,000 23,765,000 27,134,000 23,333,000 22,280,000 21,532,000 21,713,000 22,566,000 21,766,000 21,083,000 23,368,000 19,887,000 21,974,000 23,265,000 22,057,000 21,226,000 21,458,000 20,282,000 19,435,000 18,948,000 24,183,000 24,399,000 30,766,000 37,862,000 40,384,000 39,554,000 48,151,000 34,735 44,005,000 39,837,000 35,934,000 37,892,000 43,076,000 36,413,000 37,304,000 41,214,000 32,955,000 29,465,000 29,792,000 44,208,000 66,851,000 65,372,000 31,945,000 
      outstanding—23,970 shares in 2015 and 24,950 shares in 2014
                              238,000                                             
      outstanding—24,836 shares and 24,950 shares, respectively
                               247,000                                            
      outstanding—24,763 shares and 24,950 shares, respectively
                                246,000                                           
      outstanding—24,865 shares and 24,950 shares, respectively
                                 248,000                                          
      short term borrowings and current portion of long-term obligations
                                   836,000                                        
      outstanding—24,950 shares in 2014 and 24,464 shares in 2013
                                  248,000                                         
      outstanding—24,942 shares and 24,464 shares, respectively
                                   248,000                                        
      outstanding—24,870 shares and 24,464 shares, respectively
                                    248,000                                       
      outstanding—24,839 shares and 24,464 shares, respectively
                                     248,000                                      
      outstanding—24,464 shares in 2013 and 23,746 shares in 2012
                                      244,000                                     
      outstanding—24,432 shares and 23,746 shares, respectively
                                       243,000                                    
      outstanding—24,319 shares and 23,746 shares, respectively
                                        242,000                                   
      outstanding—24,041 shares and 23,746 shares, respectively
                                         240,000                                  
      outstanding—23,746 shares in 2012 and 23,722 shares in 2011
                                          237,000                                 
      outstanding—23,683 shares and 23,722 shares, respectively
                                           236,000                                
      outstanding—23,668 shares and 23,722 shares, respectively
                                            236,000                               
      outstanding—23,531 shares and 23,722 shares, respectively
                                             234,000                              
      outstanding—23,722 shares in 2011 and 24,554 shares in 2010
                                              236,000                             
      outstanding—24,976 shares and 24,554 shares, respectively
                                               249,000                            
      outstanding—25,200 shares and 24,554 shares, respectively
                                                251,000                           
      outstanding—24,836 shares and 24,455 shares, respectively
                                                 248,000                          
      outstanding—25,088 shares and 24,455 shares, respectively
                                                  250,000                         
      outstanding—24,644 shares and 24,455 shares, respectively
                                                   246,000                        
      outstanding—24,454 shares and 24,191 shares, respectively
                                                    244,000                       
      outstanding—24,388 shares and 24,191 shares, respectively
                                                     243,000                      
      outstanding—24,352 shares and 24,191 shares, respectively
                                                      242,000                     
      outstanding—23,676 shares and 31,552 shares, respectively
                                                       235,000                    
      outstanding—23,630 shares and 31,552 shares, respectively
                                                        234,000                   
      outstanding—31,546 shares and 31,552 shares, respectively
                                                         313,000                  
      restricted cash, current
                                                          2,460,000                 
      restricted cash, non-current
                                                          1,786,000 3,779                
      convertible subordinated notes
                                                          199,790,000 199,762 199,733,000 199,719,000              
      outstanding—31,553 shares and 31,412 shares, respectively
                                                          313,000                 
      notes receivable from stock sales
                                                                           
      outstanding—31,564 shares and 31,412 shares, respectively
                                                           313                
      restricted cash and cash equivalents
                                                             15,469,000 15,463,000         55,167,000    
      outstanding—31,232 shares and 31,173 shares, respectively
                                                            310,000               
      cash flows from operating activities:
                                                                           
      net income
                                                            28,340,000 17,489,000 9,316,000    5,391,000   -306,000 -45,891,000  -18,556,000 -20,483,000  
      adjustments to reconcile net income to net cash from operating activities:
                                                                           
      depreciation and amortization
                                                            19,774,000 13,181,000 6,485,000  21,448,000 14,413,000 7,310,000  15,306,000 6,859,000  21,131,000 13,957,000 6,937,000 5,480,000 
      amortization of intangible assets
                                                            6,846,000 4,641,000 2,306,000             
      deferred income taxes
                                                             572,000 2,760,000    3,393,000  7,966,000 2,012,000  13,994,000    
      stock-based compensation
                                                            10,146,000 6,735,000 3,047,000             
      excess tax benefits from stock-based payment arrangements
                                                            278,000 15,000 172,000             
      tax benefit from employee stock options
                                                                1,381,000           
      purchased in-process research and development
                                                            690,000 690,000 690,000  1,577,000           
      non-cash restructuring and other charges
                                                            97,000               
      other
                                                            459,000 102,000 63,000  1,386,000 659,000 684,000  517,000 170,000  81,000 451,000 523,000  
      changes in operating assets and liabilities, net of acquisitions:
                                                                           
      net cash from operating activities
                                                            50,833,000 33,330,000 20,522,000    29,640,000   25,358,000  11,146,000  203,000  
      cash flows from investing activities:
                                                                           
      decrease in restricted cash and cash equivalents
                                                            13,725,000               
      purchases of property and equipment
                                                                           
      proceeds from dispositions of property and equipment
                                                            1,167,000 182,000 20,000         1,886,000 903,000 826,000  
      acquisition of businesses, net of cash acquired
                                                                           
      deferred business acquisition costs
                                                                           
      purchases of available-for-sale securities
                                                                           
      proceeds from sales and maturities of available-for-sale securities
                                                            277,533,000 175,546,000 80,778,000  282,718,000 165,793,000 80,875,000  146,622,000 95,440,000      
      premiums paid on life insurance
                                                                           
      other – net
                                                            477,000           38,000    
      net cash from investing activities
                                                            85,948,000 40,956,000              
      cash flows from financing activities:
                                                                           
      proceeds received from issuance of convertible subordinated notes
                                                            200,000,000 200,000,000              
      debt issuance costs
                                                                           
      long-term debt borrowings
                                                            1,387,000 1,387,000          360,000 337,000 288,000 8,000 
      long-term debt payments
                                                                           
      cash overdrafts decrease
                                                                           
      sales of shares under employee stock plans
                                                            19,025,000 6,947,000 3,596,000  13,130,000 7,285,000 3,584,000  4,441,000 2,317,000  10,825,000 3,393,000 2,921,000 4,201,000 
      repurchase of common stock
                                                                           
      collection of notes receivable from stock sales
                                                                434,000 69,000 35,000     1,252,000 904,000 186,000 66,000 
      net cash from financing activities
                                                            179,658,000 178,301,000     1,017,000  6,499,000 1,521,000     5,246,000 
      effect of exchange rate changes on cash and cash equivalents
                                                            7,059,000 3,200,000 1,397,000   155,000 2,151,000  2,006,000 2,283,000  6,809,000 4,611,000 2,279,000  
      net increase in cash and cash equivalents
                                                            323,498,000 255,787,000 10,753,000   11,343,000 17,590,000  6,529,000 11,502,000     4,759,000 
      cash and cash equivalents, beginning of period
                                                            97,507,000 97,507,000 97,507,000   87,659,000 87,659,000  76,541,000 76,541,000  131,018,000 131,018,000 131,018,000 77,409,000 
      cash and cash equivalents, end of period
                                                            421,005,000 353,294,000 108,260,000   99,002,000 105,249,000  83,070,000 88,043,000  84,629,000 92,665,000 112,002,000 82,168,000 
      outstanding—30,720 shares and 31,173 shares, respectively
                                                             305,000              
      increase in restricted cash and cash equivalents
                                                              4,000             
      supplemental disclosure of cash flow information:
                                                                           
      cash paid during the period for:
                                                                           
      interest
                                                             659,000 546,000   1,143,000 1,104,000  1,643,000 1,494,000      
      income taxes
                                                             6,891,000 2,162,000   3,140,000 2,481,000  4,466,000 3,184,000      
      cash received during the period for:
                                                                           
      noncash investing and financing activities:
                                                                           
      tax benefit from stock option exercises
                                                             391,000 60,000   958,000 225,000  495,000 78,000   334,000 200,000  
      authorized—500,000 shares outstanding—31,043 shares and 31,173 shares, respectively
                                                              308,000             
      non-cash restructuring, impairment and other charges
                                                                3,061,000  300,000         
      other — net
                                                                           
      cash overdrafts increase
                                                              831,000      2,829,000   1,597,000  786,000  
      portion of iolon purchase price not yet paid
                                                              512,000             
      restricted cash, cash equivalents and short-term investments
                                                               15,467,000 15,466,000 15,411,000 15,336,000 15,324,000 15,282,000 15,224,000 15,284,000     
      minority interest in subsidiaries
                                                                  5,222,000 7,015,000 6,772,000 6,043,000 7,475,000 47,506,000 48,984,000 49,336,000 49,554,000 
      outstanding—31,173 shares in 2005 and 30,392 shares in 2004
                                                               309,000            
      deferred stock compensation
                                                                           
      stockholder’s equity:
                                                                           
      authorized—500,000 shares outstanding—31,103 shares and 30,392 shares, respectively
                                                                308,000           
      cash flows from continuing operating activities:
                                                                           
      income from continuing operations
                                                                34,610,000 24,965,000     -1,580 -20,842,000    
      adjustments to reconcile income from continuing operations to net cash from continuing operating activities:
                                                                           
      intangible assets amortization
                                                                4,695,000 3,021,000 1,493,000  3,699,000 1,929,000  3,179,000    
      stock based compensation
                                                                262,000           
      changes in operating assets and liabilities:
                                                                           
      net cash from continuing operating activities
                                                                72,921,000 48,704,000   33,323,000      11,137,000 
      cash flows from continuing investing activities:
                                                                           
      decrease in restricted cash, cash equivalents and short-term investments
                                                                23,644,000 8,411,000   616,000 624,000      
      proceeds from dispositions of property and equipment and assets held for sale
                                                                455,000 214,000   1,234,000 534,000      
      acquisition of businesses and minority interests, net of cash acquired
                                                                           
      distributions from deferred compensation plan arrangements
                                                                           
      net cash from continuing investing activities
                                                                           
      cash flows from continuing financing activities:
                                                                           
      net cash from continuing financing activities
                                                                 6,089,000          
      authorized—500,000 shares outstanding—30,766 shares and 30,392 shares, respectively
                                                                 306,000          
      consolidation of picometrix under fin 46r
                                                                    251,000       
      net cash from discontinued operating activities
                                                                           
      outstanding—30,570 shares and 30,392 shares, respectively
                                                                  304,000         
      gain on sale of lumenis common stock
                                                                           
      increase in restricted cash, cash equivalents and short-term investments
                                                                           
      cash paid during the quarter for:
                                                                           
      cash received during the quarter for:
                                                                           
      authorized—500,000 shares outstanding—30,317 shares and 29,939 shares, respectively
                                                                   301,000        
      outstanding—30,177 shares and 29,939 shares, respectively
                                                                    300,000       
      net income from continuing operations
                                                                    2,579,000       
      adjustments to reconcile net income from continuing operations to net cash from continuing operating activities:
                                                                           
      purchases of short-term trading investments
                                                                           
      proceeds from sales and maturities of short-term trading investments
                                                                       178,241,000    
      write-down of lumenis investment
                                                                       10,212,000 10,212,000 10,212,000  
      write-down of notes receivable from picometrix
                                                                       3,723,000 3,723,000 3,723,000  
      changes in operating assets and liabilities
                                                                    3,256,000 14,788,000   13,438,000   
      short-term repayments
                                                                           
      net cash from discontinued operations
                                                                    218,000       
      accounts receivable-net of allowances of 4,588 and 4,151, respectively
                                                                     74,229,000      
      authorized—500,000 shares outstanding—30,059 shares and 29,939 shares, respectively
                                                                     301,000      
      outstanding—29,939 shares in 2003 and 29,042 shares in 2002
                                                                      298,000     
      net sales
                                                                      406,235,000     
      cost of sales
                                                                      257,467,000     
      gross profit
                                                                      148,768,000     
      operating expenses:
                                                                           
      research and development
                                                                      50,751,000     
      in-process research and development
                                                                      6,338,000 4,430,000    
      selling, general and administrative
                                                                      103,929,000     
      restructuring, impairment and other charges
                                                                      35,163,000     
      intangibles amortization
                                                                      5,147,000  1,782,000 835,000 908,000 
      total operating expenses
                                                                      201,328,000     
      income from operations
                                                                           
      other income:
                                                                           
      interest and dividend income
                                                                      5,371,000     
      interest expense
                                                                           
      foreign exchange loss
                                                                           
      other—net
                                                                      5,680,000    1,340,000 
      total other income
                                                                           
      income from continuing operations before income taxes and minority interest
                                                                           
      benefit for income taxes
                                                                           
      income from continuing operations before minority interest
                                                                           
      minority interest in subsidiaries’ (earnings) losses
                                                                      4,241,000     
      discontinued operations, net of income taxes
                                                                           
      gain on disposal of medical segment
                                                                      642,000     
      income from discontinued medical segment
                                                                           
      income before accounting changes
                                                                           
      cumulative effect of accounting change
                                                                           
      net income per basic share:
                                                                           
      income from discontinued operations, net of income taxes
                                                                      20     
      net income per diluted share:
                                                                           
      shares used in computation:
                                                                           
      basic
                                                                      29,448,000     
      diluted
                                                                      29,448,000     
      accumulated depreciation and amortization
                                                                           
      property and equipment—net
                                                                       158,542,000 155,848,000 153,991,000  
      adjustments to reconcile income from continuing operations to net cash from operating activities:
                                                                           
      restructuring and impairment charges
                                                                       17,182,000 16,843,000 16,438,000  
      goodwill impairment
                                                                       2,358,000 2,358,000   
      purchases of available-for-sale investments
                                                                           
      proceeds from sales and maturities of available-for-sale investments
                                                                       146,798,000    
      issuance of notes related to sale of common stock
                                                                           
      repayment of acquisition obligation through issuance of common stock
                                                                           
      portion of purchase price related to pli acquisition included in other current liabilities
                                                                       2,239,000    
      purchased intangibles
                                                                        28,213,000   
      authorized—500,000 shares outstanding—29,290 shares and 29,042 shares, respectively
                                                                        291,000   
      proceeds from sales of short-term trading investments
                                                                        178,241,000 84,243,000 26,600,000 
      acquisition of business, net of cash acquired
                                                                           
      other - net
                                                                        1,487,000 978,000  
      goodwill—net of accumulated amortization of 10,644
                                                                         34,775,000  
      authorized—500,000 shares outstanding—29,241 shares and 29,042 shares, respectively
                                                                         291,000  
      property and equipment-net
                                                                          174,191,000 
      goodwill—net of accumulated amortization of 10,897
                                                                          31,830,000 
      income from continuing operations after accounting changes
                                                                          2,730,000 
      adjustments to reconcile income from continuing operations after accounting changes to net cash from operating activities:
                                                                           
      cumulative effect of accounting changes
                                                                           
      other adjustments
                                                                          634,000 
      cash overdrafts
                                                                           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.